Detalles de la búsqueda
1.
Synthesis and activity of newly designed aroxyalkyl or aroxyethoxyethyl derivatives of piperazine on the cardiovascular and the central nervous systems.
Bioorg Med Chem Lett
; 26(21): 5315-5321, 2016 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27692547
2.
Synthesis and evaluation of anticonvulsant activity of N-(2,5-dimethylphenoxy)- and N-[(2,3,5-trimethylphenoxy)alkyl]aminoalkanols.
Acta Pol Pharm
; 72(1): 89-99, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25850204
3.
The nitric oxide/soluble cyclic guanylase/cyclic guanosine monophosphate pathway is involved in the cardiovascular effects of a novel α1- and ß-adrenoceptor antagonist.
Pharmacology
; 94(5-6): 287-95, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25531925
4.
Reversal of cardiac, vascular, and renal dysfunction by non-quinazoline α1-adrenolytics in DOCA-salt hypertensive rats: a comparison with prazosin, a quinazoline-based α1-adrenoceptor antagonist.
Hypertens Res
; 42(8): 1125-1141, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30872813
5.
Anti-aggregation effect of aroxyalkyl derivatives of 2-methoxyphenylpiperazine is due to their 5-HT2A and α2-adrenoceptor antagonistic properties. A comparison with ketanserin, sarpogrelate, prazosin, yohimbine and ARC239.
Eur J Pharmacol
; 818: 263-270, 2018 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29111111
6.
Involvement of the NO/sGC/cGMP/K+ channels pathway in vascular relaxation evoked by two non-quinazoline α1-adrenoceptor antagonists.
Biomed Pharmacother
; 103: 157-166, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29653360
7.
Preliminary assessment of mutagenic and anti-mutagenic potential of some aminoalkanolic derivatives of xanthone by use of the Vibrio harveyi assay.
Mutat Res Genet Toxicol Environ Mutagen
; 768: 8-13, 2014 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24769486
Resultados
1 -
7
de 7
1
Próxima >
>>